Home › Compare › HMTXF vs FCPT

HMTXF vs FCPT: Dividend Comparison 2026

HMTXF yields 4072.49% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HMTXF wins by $8532781061001.08M in total portfolio value
10 years
HMTXF
HMTXF
● Live price
4072.49%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8532781061001.13M
Annual income
$8,139,610,200,782,360,000.00
Full HMTXF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — HMTXF vs FCPT

📍 HMTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHMTXFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HMTXF + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HMTXF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HMTXF
Annual income on $10K today (after 15% tax)
$346,161.68/yr
After 10yr DRIP, annual income (after tax)
$6,918,668,670,665,005,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, HMTXF beats the other by $6,918,668,670,665,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HMTXF + FCPT for your $10,000?

HMTXF: 50%FCPT: 50%
100% FCPT50/50100% HMTXF
Portfolio after 10yr
$4266390530500.59M
Annual income
$4,069,805,100,391,183,000.00/yr
Blended yield
95.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

HMTXF
No analyst data
Altman Z
-77.1
Piotroski
3/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HMTXF buys
0
FCPT buys
0
No recent congressional trades found for HMTXF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHMTXFFCPT
Forward yield4072.49% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$8532781061001.13M ✓$49.1K
Annual income after 10y$8,139,610,200,782,360,000.00 ✓$5,775.28
Total dividends collected$8505980562203.27M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HMTXF vs FCPT ($10,000, DRIP)

YearHMTXF PortfolioHMTXF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$417,949$407,249.03$11,401$700.92+$406.5K → HMTXF
2$16,354,620$15,907,414.89$13,064$864.84+$16.34M → HMTXF
3$599,244,865$581,745,420.76$15,051$1,072.48+$599.23M → HMTXF
4$20,562,279,794$19,921,087,789.34$17,442$1,337.22+$20562.26M → HMTXF
5$660,847,691,261$638,846,051,880.89$20,340$1,677.08+$660847.67M → HMTXF
6$19,895,674,352,505$19,188,567,322,855.41$23,880$2,116.57+$19895674.33M → HMTXF
7$561,191,767,703,669$539,903,396,146,489.40$28,241$2,689.36+$561191767.68M → HMTXF
8$14,833,096,999,026,612$14,232,621,807,583,686.00$33,660$3,442.07+$14833096998.99M → HMTXF
9$367,449,402,073,618,800$351,577,988,284,660,350.00$40,456$4,439.95+$367449402073.58M → HMTXF
10$8,532,781,061,001,133,000$8,139,610,200,782,360,000.00$49,063$5,775.28+$8532781061001.08M → HMTXF

HMTXF vs FCPT: Complete Analysis 2026

HMTXF — Stock

Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

Full HMTXF Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this HMTXF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HMTXF vs SCHDHMTXF vs JEPIHMTXF vs OHMTXF vs KOHMTXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.